Topics

Articles

The parties’ combined portfolio help tackle the rising demand for advanced cell and gene therapies.  

MilliporeSigma Finalizes Mirus Bio Deal

Gallagher’s 2024 US Physical & Emotional Wellbeing Report outlines ways to meeting evolving needs in the workforce. 

Mental Health, Rising Healthcare Costs Headline Employer and Employee Concerns 

The partnership—which features a $150 million investment—is also centered around vaccine development in the respiratory and immunology space.  


GSK, Flagship Pioneering Collaborate on Novel Medicine Discovery

The acquisition provides Ardian with greater insight into the life science industry.

Ardian Buys Majority Stake in Masco Group 

The parties will continue to create new candidate therapies for the treatment of a severe form of TUBB4A leukodystrophy.

SynaptixBio, Evotec Extend Research and Development Collaboration

The deal exponentially grows the CDMO’s biopharma capabilities.

Agilent Purchases Biovectra for $925 Million

In a transaction valued at $250 million, the deal makes Grünenthal the new owner of Movantik, which treats OIC in adult patients with chronic non-cancer pain. 

Grünenthal Obtains Valinor Pharma 

The financial commitment includes a pair of expansion plans occurring in the United States and Europe. 

Cordenpharma Invests $984 Million into Its Peptide Tech Platform

The clinical supply facility undergoes a $25 million expansion, welcoming 32,000 more square feet of temperature-controlled storage.

Catalent Finalizes Schorndorf Plant Development Project

The construction of 100,000 square-foot facility will boost the site's filling capacity to 140 million units per year.

Business and Finance